Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Hyper GP (tisilfocon A) Daily Wear Contact Lens

K-Number: K182304 · 2018-11-23

Decision Date2018-11-23
Product CodeHQD
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

Hyper GP (tisilfocon A) Daily Wear Contact Lens is a medical device manufactured by Contamac, Ltd.. It received FDA 510(k) clearance on 2018-11-23 under approval number K182304. The device is classified under product code HQD. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Hyper GP (tisilfocon A) Daily Wear Contact Lens?

Hyper GP (tisilfocon A) Daily Wear Contact Lens is a medical device that received FDA 510(k) clearance on 2018-11-23. It is manufactured by Contamac, Ltd.. The 510(k) number is K182304.

When was Hyper GP (tisilfocon A) Daily Wear Contact Lens approved by the FDA?

Hyper GP (tisilfocon A) Daily Wear Contact Lens received FDA 510(k) clearance on 2018-11-23, under approval number K182304.

What company makes Hyper GP (tisilfocon A) Daily Wear Contact Lens?

Hyper GP (tisilfocon A) Daily Wear Contact Lens is manufactured by Contamac, Ltd..

What is the FDA product code for Hyper GP (tisilfocon A) Daily Wear Contact Lens?

The FDA product code for Hyper GP (tisilfocon A) Daily Wear Contact Lens is HQD.

Related Clinical Trials

Other Devices by Contamac, Ltd.

View all 9 devices →

Related Devices (Code: HQD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.